IL-24 can also enhance immunogenicity of tumor cells by upregulating costimulatory molecules such as CD80 and CD86 on tumor cells.18, 19 Therefore, IL-24 may enhance therapeutic effects of ATV-NDV. The gene discussed is CD86; the disease is neoplasm.